Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1) an-label, 2 trial

de Bono, Johann S.; Mehra, Niven; Scagliotti, Giorgio, V; Castro, Elena; Dorff, Tanya; Stirling, Adam; Stenzl, Arnulf; Fleming, Mark T.; Higano, Celestia S.; Saad, Fred; Buttigliero, Consuelo; van Oort, Inge M.; Laird, A. Douglas; Mata, Marielena; Chen, Hsiang-Chun; Healy, Cynthia G.; Czibere, Akos; Fizazi, Karim

dc.contributor.author	Stenzl, Arnulf
dc.date.accessioned	2022-03-21T08:58:17Z
dc.date.available	2022-03-21T08:58:17Z
dc.date.issued	2021
dc.identifier.issn	1474-5488
dc.identifier.uri	http://hdl.handle.net/10900/125452
dc.language.iso	en	de_DE
dc.publisher	Elsevier Science Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/S1470-2045(21)00376-4	de_DE
dc.subject.ddc	610	de_DE
dc.title	Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1) an-label, 2 trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20211125174918_00818
utue.publikation.seiten	1250-1264	de_DE
utue.personen.roh	de Bono, Johann S.
utue.personen.roh	Mehra, Niven
utue.personen.roh	Scagliotti, Giorgio, V
utue.personen.roh	Castro, Elena
utue.personen.roh	Dorff, Tanya
utue.personen.roh	Stirling, Adam
utue.personen.roh	Stenzl, Arnulf
utue.personen.roh	Fleming, Mark T.
utue.personen.roh	Higano, Celestia S.
utue.personen.roh	Saad, Fred
utue.personen.roh	Buttigliero, Consuelo
utue.personen.roh	van Oort, Inge M.
utue.personen.roh	Laird, A. Douglas
utue.personen.roh	Mata, Marielena
utue.personen.roh	Chen, Hsiang-Chun
utue.personen.roh	Healy, Cynthia G.
utue.personen.roh	Czibere, Akos
utue.personen.roh	Fizazi, Karim
dcterms.isPartOf.ZSTitelID	Lancet Oncology	de_DE
dcterms.isPartOf.ZS-Issue	9	de_DE
dcterms.isPartOf.ZS-Volume	22	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE